How low should we go? The search for balance in management of small human epidermal growth factor receptor 2-positive breast cancers

J Clin Oncol. 2014 Jul 10;32(20):2122-4. doi: 10.1200/JCO.2014.55.7249. Epub 2014 Jun 2.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / analysis*
  • Breast Neoplasms / chemistry*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology*
  • Female
  • Humans
  • Neoplasm Recurrence, Local / chemistry*
  • Neoplasm Recurrence, Local / drug therapy*
  • Receptor, ErbB-2 / analysis*
  • Trastuzumab

Substances

  • Antibodies, Monoclonal, Humanized
  • Biomarkers, Tumor
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • Trastuzumab